Slideshow
Author(s):
Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.
Holistic Personalized Care for Patients with Multiple Sclerosis and the Importance of Cognitive Monitoring
Special Episode: FDA Approves Sodium Oxybate for Pediatric Narcolepsy
This Week on NeurologyLive® — October 28, 2024
Episode 126: Exploring the Therapeutic Potential of ATH434 in Multiple System Atrophy
Nonopioid Medication Overuse Headache Remission Observed With Erenumab
NeurologyLive® Brain Games: October 27, 2024